Diseases · Entity Annotation Prototype (beta)

2articles mentioning diseases

5disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: mPDAC ×

mPDAC

This disease is selected. Its supporting articles are shown below.

mPDAC2

Articles mentioning mPDAC

2 articles · page 1 of 1

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma

jitc · abstract · 2026-01-30 · 3 matching annotations

88.8%

mPDAC metastatic pancreatic ductal adenocarcinoma (mPDAC)hydroxychloroquine gemcitabine nivolumab ipilimumab nab-paclitaxel hydroxychloroquine-related cytotoxic therapy chemoimmunotherapy combinations+2 more

…esults reinforce the continued promise of chemoimmunotherapy in mPDAC and the importance of refining these strategies.…

530 CD40 agonist mitazalimab + mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma: dose characterization based on exposure response and biomarker analysis from the OPTIMIZE-1 study

jitc · abstract · 2025-11-04 · 2 matching annotations

91.1%

metastatic pancreatic ductal adenocarcinoma mPDAC Mitazalimab mFOLFIRINOX